CINCINNATI, Oct. 13, 2020 /PRNewswire/ — Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced today the appointment of Jennie Orr as Chief Strategy and Business Officer. In this newly created senior leadership role, Orr will lead the development, communication and execution of corporate strategic growth initiatives including both organic growth and its mergers and acquisitions activities.
“Jennie has consistently demonstrated her strong leadership abilities and her dedication to Camargo’s values since she joined us in 2018,” Camargo CEO Dan Duffy said. “Having her in this position will enable us to advance our operational vision and achieve our growth expectations for the future.”
Camargo is a leading global strategy, regulatory and commercial partner for emerging and mid-size biopharma companies and has been instrumental in helping numerous pharmaceutical companies identify opportunities, develop products and obtain FDA approvals. Its work in orphan drugs, improved drugs, oncology and many